研究目的
To evaluate the long-term efficacy of multimodal therapy in pediatric patients treated for keloids at the Sainte-Justine University Hospital Center.
研究成果
Multimodal therapy, consisting of surgical excision combined with CO2 laser therapy, TAC injections, silicone, and pressure devices, seems to be efficient in the treatment of keloids and the prevention of their recurrence in a pediatric population. Close follow-up is needed to reassess the need for additional treatment. A randomized controlled trial would be necessary to assess the real benefit of this treatment combination in children.
研究不足
The study's limitations include significant postinflammatory hypopigmentation and telangiectases, a significant number of patients lost to follow-up (33.3%), and the use of general anesthesia which may not be necessary for all patients.
1:Experimental Design and Method Selection:
A retrospective case study was conducted on 21 children with keloids treated between April 2006 and April
2:The study evaluated the combination of surgical excision, carbon dioxide (CO2) laser therapy on the surgical site, and triamcinolone acetonide (TAC) intralesional injections during surgery and follow-up. Sample Selection and Data Sources:
20 The study included 21 children aged 2-15 years with keloids, primarily on the ear, treated at the Sainte-Justine University Hospital Center.
3:List of Experimental Equipment and Materials:
The equipment used included a fully ablative CO2 laser (Ultrapulse by Lumenis) and a number 11 or 15 scalpel blade for surgical excision. Materials included triamcinolone acetonide (TAC) for injections, pressure garments, and topical silicone.
4:Experimental Procedures and Operational Workflow:
The procedure involved surgical excision followed immediately by CO2 laser therapy on the surgical site and TAC injections. Follow-up visits were scheduled at 1, 2, 4, and 6-month intervals over 2 years.
5:Data Analysis Methods:
The study analyzed the recurrence rate and clearance of keloids in patients with adequate follow-up.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容